Skip to main content
Human Metabolome Technologies, Inc. logo

Human Metabolome Technologies, Inc. — Investor Relations & Filings

Ticker · 6090 ISIN · JP3794530000 T Professional, scientific and technical activities
Open in API
Filings indexed 73 across all filing types
Latest filing 2021-09-27 Governance Information
Country JP Japan
Listing T 6090

About Human Metabolome Technologies, Inc.

https://humanmetabolome.com/

Human Metabolome Technologies, Inc. is a biotechnology company specializing in metabolomics. As a pioneer and global leader in the field, it leverages proprietary capillary electrophoresis mass spectrometry (CE-MS) based technology for comprehensive metabolome analysis. The company provides a range of analytical services, including global profiling, targeted assays, metabolic flux analysis, and lipidomics. These services support research and development projects, particularly in biomarker discovery and drug development, by delivering high-quality metabolomics data to address complex scientific and medical challenges.

Recent filings

Filing Released Lang Actions
内部統制報告書－第18期(令和2年7月1日－令和3年6月30日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法). This is a specific regulatory requirement in Japan regarding the assessment of internal controls over financial reporting. Since it is a standalone regulatory filing concerning internal control assessment and does not fit into the other specific categories like 10-K or AR (which are broader financial reports), it is best classified as a Regulatory Filing (RNS).
2021-09-27 Japanese
有価証券報告書－第18期(令和2年7月1日－令和3年6月30日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Annual Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, management discussion, and business information for the fiscal year ending June 30, 2021. It is a full-length regulatory filing, not an announcement or a summary. FY 2021
2021-09-27 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan, which accompanies the Annual Securities Report (Yukashoken Hokokusho). Since it is a regulatory filing confirming the accuracy of the annual report and does not contain the full financial statements or the report itself, it falls under the category of general regulatory filings. FY 2021
2021-09-27 Japanese
四半期報告書－第18期第3四半期(令和3年1月1日－令和3年3月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Human Metabolome Technologies, Inc., covering the third quarter of the 18th fiscal year (January 1, 2021, to March 31, 2021). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements and segment information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2021
2021-05-12 Japanese
四半期報告書－第18期第2四半期(令和2年10月1日－令和2年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, including the balance sheet, income statement, and cash flow statement for the second quarter of the 18th fiscal period. It is not an announcement or a summary, but the full statutory report itself, which fits the definition of an Interim/Quarterly Report (IR). H1 2021
2021-02-12 Japanese
四半期報告書－第18期第1四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Human Metabolome Technologies, Inc., covering the first quarter of the 18th fiscal year (July 1, 2020, to September 30, 2020). It contains detailed financial statements, including the balance sheet, income statement, and segment information, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2021
2020-11-12 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.